SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-406371
Filing Date
2015-12-17
Accepted
2015-12-17 17:08:30
Documents
60
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d25307d10q.htm 10-Q 605226
2 EX-31.1 d25307dex311.htm EX-31.1 8091
3 EX-31.2 d25307dex312.htm EX-31.2 8125
4 EX-32.1 d25307dex321.htm EX-32.1 3630
5 EX-32.2 d25307dex322.htm EX-32.2 3678
  Complete submission text file 0001193125-15-406371.txt   3073573

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT wve-20150930.xml EX-101.INS 352264
7 XBRL TAXONOMY EXTENSION SCHEMA wve-20150930.xsd EX-101.SCH 37676
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wve-20150930_cal.xml EX-101.CAL 51631
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wve-20150930_def.xml EX-101.DEF 177891
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20150930_lab.xml EX-101.LAB 332929
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20150930_pre.xml EX-101.PRE 260757
Mailing Address 8 CROSS STREET #10-00 SINGAPORE U0 048424
Business Address 8 CROSS STREET #10-00 SINGAPORE U0 048424 617-206-4830
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37627 | Film No.: 151294401
SIC: 2834 Pharmaceutical Preparations